Owens & Minor (OMI) | Financial Analysis & Statements
Owens & Minor Inc. Micro-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
709.0M
Gross Profit
323.3M
45.60%
Operating Income
51.8M
7.30%
Net Income
-56.3M
-7.94%
Balance Sheet Metrics
Total Assets
2.5B
Total Liabilities
2.9B
Shareholders Equity
-461.0M
Cash Flow Metrics
Operating Cash Flow
441.8M
Free Cash Flow
58.9M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Owens & Minor Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.8B | 10.7B | 10.3B | 10.0B | 9.8B |
| Cost of Goods Sold | 1.5B | 8.5B | 8.2B | 8.1B | 8.3B |
| Gross Profit | 1.3B | 2.2B | 2.1B | 1.8B | 1.5B |
| Gross Margin % | 46.7% | 20.7% | 20.6% | 18.3% | 15.5% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 1.1B | 1.9B | 1.8B | 1.6B | 1.1B |
| Other Operating Expenses | - | 13.3M | 6.9M | -5.3M | -6.2M |
| Total Operating Expenses | 1.1B | 1.9B | 1.8B | 1.5B | 1.1B |
| Operating Income | 221.7M | 296.0M | 304.7M | 276.8M | 442.4M |
| Operating Margin % | 8.0% | 2.8% | 2.9% | 2.8% | 4.5% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 107.2M | 143.8M | 157.9M | 128.9M | 48.1M |
| Other Non-Operating Income | -216.5M | -509.6M | -201.5M | -137.0M | -117.5M |
| Pre-tax Income | -102.0M | -357.4M | -54.7M | 10.9M | 276.8M |
| Income Tax | 729.0K | 5.3M | -13.4M | -11.5M | 55.2M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | -105.6% | 19.9% |
| Net Income | -1.1B | -362.7M | -41.3M | 22.4M | 221.6M |
| Net Margin % | -39.8% | -3.4% | -0.4% | 0.2% | 2.3% |
| Key Metrics | |||||
| EBITDA | 432.3M | 556.1M | 587.2M | 502.3M | 529.8M |
| EPS (Basic) | - | $-4.73 | $-0.54 | $0.30 | $3.05 |
| EPS (Diluted) | - | $-4.73 | $-0.54 | $0.29 | $2.94 |
| Basic Shares Outstanding | - | 76741000 | 75785000 | 74496000 | 72744000 |
| Diluted Shares Outstanding | - | 76741000 | 75785000 | 74496000 | 72744000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Owens & Minor Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 282.0M | 49.4M | 243.0M | 69.5M | 55.7M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 95.9M | 690.2M | 598.3M | 763.5M | 681.6M |
| Inventory | 74.4M | 1.1B | 1.1B | 1.3B | 1.5B |
| Other Current Assets | 95.5M | 149.5M | 150.9M | 128.6M | 88.6M |
| Total Current Assets | 547.9M | 2.0B | 2.1B | 2.3B | 2.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 559.3M | 744.1M | 658.7M | 604.7M | 194.0M |
| Goodwill | 2.6B | 3.0B | 3.6B | 3.7B | 990.1M |
| Intangible Assets | 136.5M | 296.7M | 361.8M | 445.0M | 209.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 174.0M | 140.2M | 149.3M | 150.4M | 103.6M |
| Total Non-Current Assets | 1.9B | 2.6B | 3.0B | 3.1B | 1.2B |
| Total Assets | 2.5B | 4.7B | 5.1B | 5.4B | 3.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 363.6M | 1.3B | 1.2B | 1.1B | 1.0B |
| Short-term Debt | 250.0M | 45.2M | 206.9M | 17.9M | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 264.1M | 425.5M | 396.7M | 307.8M | 226.2M |
| Total Current Liabilities | 947.1M | 1.9B | 1.9B | 1.6B | 1.3B |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.9B | 2.1B | 2.1B | 2.7B | 1.1B |
| Deferred Tax Liabilities | 0 | 22.5M | 41.7M | 60.8M | 35.3M |
| Other Non-Current Liabilities | 95.5M | 100.1M | 122.6M | 114.9M | 108.9M |
| Total Non-Current Liabilities | 2.0B | 2.2B | 2.3B | 2.9B | 1.3B |
| Total Liabilities | 2.9B | 4.1B | 4.2B | 4.4B | 2.6B |
| Equity | |||||
| Common Stock | 152.8M | 154.4M | 153.1M | 152.6M | 150.9M |
| Retained Earnings | -1.1B | 6.0M | 368.7M | 410.0M | 387.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -461.0M | 565.2M | 924.2M | 945.6M | 938.5M |
| Key Metrics | |||||
| Total Debt | 2.1B | 2.1B | 2.3B | 2.7B | 1.1B |
| Working Capital | -399.2M | 147.3M | 210.9M | 728.7M | 977.8M |
Balance Sheet Composition
Owens & Minor Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -102.7M | -362.7M | -41.3M | 22.4M | 221.6M |
| Depreciation & Amortization | 214.5M | 264.8M | 287.4M | 228.7M | 90.6M |
| Stock-Based Compensation | 12.9M | 26.8M | 23.2M | 21.0M | 25.0M |
| Working Capital Changes | 65.2M | -25.4M | 522.3M | 89.8M | -261.4M |
| Operating Cash Flow | 181.8M | -102.0M | 780.5M | 348.0M | 62.6M |
| Investing Activities | |||||
| Capital Expenditures | -113.0M | -107.4M | -119.3M | -109.7M | -41.0M |
| Acquisitions | 324.3M | 0 | 0 | -1.7B | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 209.4M | -99.2M | -120.2M | -1.8B | -44.9M |
| Financing Activities | |||||
| Share Repurchases | -10.2M | - | - | - | - |
| Dividends Paid | - | - | 0 | 0 | -731.0K |
| Debt Issuance | 2.9B | 2.1B | 476.0M | 2.7B | 574.9M |
| Debt Repayment | -2.7B | -2.3B | -892.7M | -1.2B | -553.1M |
| Financing Cash Flow | 190.2M | -267.6M | -417.3M | 1.5B | -114.0M |
| Free Cash Flow | -303.1M | -66.7M | 532.8M | 158.4M | 74.5M |
| Net Change in Cash | 581.3M | -468.9M | 243.0M | 49.1M | -96.4M |
Cash Flow Trend
Owens & Minor Key Financial Ratios
Valuation Ratios
Forward P/E
2.88
Price to Sales
0.02
PEG Ratio
2.88
Profitability Ratios
Profit Margin
-12.45%
Operating Margin
8.08%
Return on Equity
-196.39%
Return on Assets
3.75%
Financial Health
Current Ratio
0.86
Debt to Equity
-4.86
Beta
1.36
Per Share Data
EPS (TTM)
$-5.69
Book Value per Share
$-5.56
Revenue per Share
$139.77
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| OMI | 184.1M | - | - | -196.39% | -12.45% | -4.86 |
| McKesson | 103.2B | 24.33 | -1,040.14 | -194.51% | 1.09% | -88.23 |
| Cencora | 60.6B | 37.46 | 31.84 | 133.47% | 0.50% | 472.58 |
| Quipt Home Medical | 162.3M | 493.00 | 1.59 | -9.31% | -4.03% | 102.33 |
| Cosmos Health | 18.1M | - | 0.78 | -89.13% | -29.33% | 108.39 |
| Synergy CHC | 5.2M | 3.86 | - | 53.36% | -40.62% | -1.16 |
Financial data is updated regularly. All figures are in the company's reporting currency.





